71 related articles for article (PubMed ID: 38536153)
1. Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction.
McDowell K; Kondo T; Talebi A; Teh K; Bachus E; de Boer RA; Campbell RT; Claggett B; Desai AS; Docherty KF; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Simpson J; Vaduganathan M; Jhund PS; Solomon SD; McMurray JJV
JAMA Cardiol; 2024 May; 9(5):457-465. PubMed ID: 38536153
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction - a randomized trial: The NICE study.
Pascual-Figal DA; Hernández-Vicente A; Pastor-Pérez F; Martínez-Sellés M; Solé-González E; Alvarez-García J; García-Pavía P; Varela-Román A; Sánchez PL; Delgado JF; Noguera-Velasco JA; Bayes-Genis A;
Eur J Heart Fail; 2024 Apr; 26(4):776-784. PubMed ID: 38606524
[TBL] [Abstract][Full Text] [Related]
3. Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial.
Mc Causland FR; Claggett BL; Vaduganathan M; Desai A; Jhund P; Vardeny O; Fang JC; de Boer RA; Docherty KF; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Saraiva JFK; McGrath MM; Shah SJ; Verma S; Langkilde AM; Petersson M; McMurray JJV; Solomon SD
JAMA Cardiol; 2024 Feb; 9(2):144-152. PubMed ID: 37952176
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.
Ferreira JP; Packer M; Sattar N; Butler J; González Maldonado S; Panova-Noeva M; Sumin M; Masson S; Pocock SJ; Anker SD; Zannad F; Januzzi JL
Eur J Heart Fail; 2024 Apr; 26(4):806-816. PubMed ID: 38587259
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
Peikert A; Vaduganathan M; Claggett BL; Kulac IJ; Foà A; Desai AS; Jhund PS; Carberry J; Lam CSP; Kosiborod MN; Inzucchi SE; Martinez FA; de Boer RA; Hernandez AF; Shah SJ; Køber L; Ponikowski P; Sabatine MS; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
Eur J Heart Fail; 2024 Apr; 26(4):912-924. PubMed ID: 38487939
[TBL] [Abstract][Full Text] [Related]
6. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.
Parikh RH; Seliger SL; Christenson R; Gottdiener JS; Psaty BM; deFilippi CR
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481133
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial.
Sattar N; Butler J; Lee MMY; Harrington J; Sharma A; Zannad F; Filippatos G; Verma S; Januzzi JL; Ferreira JP; Pocock SJ; Pfarr E; Ofstad AP; Brueckmann M; Packer M; Anker SD
Eur J Heart Fail; 2024 Apr; 26(4):900-909. PubMed ID: 38558521
[TBL] [Abstract][Full Text] [Related]
8. Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes.
Ho JE; Enserro D; Brouwers FP; Kizer JR; Shah SJ; Psaty BM; Bartz TM; Santhanakrishnan R; Lee DS; Chan C; Liu K; Blaha MJ; Hillege HL; van der Harst P; van Gilst WH; Kop WJ; Gansevoort RT; Vasan RS; Gardin JM; Levy D; Gottdiener JS; de Boer RA; Larson MG
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266854
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.
Ferreira JP; Zannad F; Packer M; Filippatos G; Pocock SJ; Vasques-Nóvoa F; Böhm M; Butler J; Anker S
Eur J Heart Fail; 2024 Apr; 26(4):952-959. PubMed ID: 38439585
[TBL] [Abstract][Full Text] [Related]
10. A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials.
Kondo T; Jhund PS; Gasparyan SB; Yang M; Claggett BL; McCausland FR; Tolomeo P; Vadagunathan M; Heerspink HJL; Solomon SD; McMurray JJV
Nat Med; 2024 May; 30(5):1432-1439. PubMed ID: 38710952
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
Ferreira JP; Packer M; Sattar N; Butler J; Pocock SJ; Anker SD; Maldonado SG; Panova-Noeva M; Sumin M; Masson S; Zannad F; Januzzi JL
Eur J Heart Fail; 2024 Apr; 26(4):788-802. PubMed ID: 38439582
[TBL] [Abstract][Full Text] [Related]
12. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community.
Selvaraj S; Myhre PL; Vaduganathan M; Claggett BL; Matsushita K; Kitzman DW; Borlaug BA; Shah AM; Solomon SD
JACC Heart Fail; 2020 Aug; 8(8):640-653. PubMed ID: 32535127
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.
Parrinello CM; Matsushita K; Woodward M; Wagenknecht LE; Coresh J; Selvin E
Diabetes Obes Metab; 2016 Sep; 18(9):899-906. PubMed ID: 27161077
[TBL] [Abstract][Full Text] [Related]
14. [New perspectives in the diagnosis and treatment of heart failure with preserved ejection fraction (HFpEF)].
Brandner J; Tessitore E; Guijarro D; Valiton V; Poku NK; Hullin R; Meyer P
Rev Med Suisse; 2024 May; 20(875):1005-1009. PubMed ID: 38783669
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram model for all-cause mortality risk in patients with chronic heart failure and atrial fibrillation.
Guan L; Wang CH; Sun H; Sun ZJ
BMC Geriatr; 2024 May; 24(1):470. PubMed ID: 38811919
[TBL] [Abstract][Full Text] [Related]
16. Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF.
Wang S; Chen Y; Ma H; Wang Y; Luo M; Xie X; Yang Q; Lin K; Lin M; Lin L; Chen P; Zheng Q; Sun F
Curr Gene Ther; 2024; 24(4):321-330. PubMed ID: 38310459
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis.
Segar MW; Jaeger BC; Patel KV; Nambi V; Ndumele CE; Correa A; Butler J; Chandra A; Ayers C; Rao S; Lewis AA; Raffield LM; Rodriguez CJ; Michos ED; Ballantyne CM; Hall ME; Mentz RJ; de Lemos JA; Pandey A
Circulation; 2021 Jun; 143(24):2370-2383. PubMed ID: 33845593
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease.
Bonacchi G; Rossi VA; Garofalo M; Mollace R; Uccello G; Pieragnoli P; Checchi L; Perrotta L; Voltolini L; Ricciardi G; Beltrami M
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790943
[TBL] [Abstract][Full Text] [Related]
19. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk.
Ambrosy AP; Chang AJ; Davison B; Voors A; Cohen-Solal A; Damasceno A; Kimmoun A; Lam CSP; Edwards C; Tomasoni D; Gayat E; Filippatos G; Saidu H; Biegus J; Celutkiene J; Ter Maaten JM; Čerlinskaitė-Bajorė K; Sliwa K; Takagi K; Metra M; Novosadova M; Barros M; Adamo M; Pagnesi M; Arrigo M; Chioncel O; Diaz R; Pang PS; Ponikowski P; Cotter G; Mebazaa A
JACC Heart Fail; 2024 May; ():. PubMed ID: 38739123
[TBL] [Abstract][Full Text] [Related]
20. Renal perturbations with sodium-glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction.
Vanhentenrijk S; Tang WHW
Eur J Heart Fail; 2024 Apr; 26(4):897-899. PubMed ID: 38501484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
